Showing results (191-200 of 946) with videos related to
Sort By:
Pageof 95
Annals of Neurology|January 1, 1992
Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research GroupP Jenner, D T Dexter, J Sian, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1997
Glutathione depletion in rat brain does not cause nigrostriatal pathway degenerationS Toffa, G M Kunikowska, B Y Zeng, et al.Neuroreport|May 20, 1998
L-arginine produces NO-independent increases in dopamine efflux in rat striatumM T Silva, S Rose, J G Hindmarsh, et al.Biochemical Pharmacology|May 15, 1985
SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptorsS Boyce, E Kelly, A Davis, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Do enkephalins in basal ganglia mediate a physiological motor rest mechanism?M L de Ceballos, M Baker, S Rose, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
The evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineW R Gibb, M Terruli, A J Lees, et al.European Journal of Pharmacology|November 1, 1988
The D-1 dopamine receptor partial agonist, CY 208-243, exhibits antiparkinsonian activity in the MPTP-treated marmosetJ A Temlett, P N Chong, W H Oertel, et al.Biochemical Pharmacology|February 1, 1982
Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivityP Jenner, M D Hall, K Murugaiah, et al.Synapse (New York, N.Y.)|June 1, 1993
Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic studyK K Gnanalingham, L A Smith, A J Hunter, et al.Pageof 95